NCT01149018

Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia

A Randomized, Double-blind, Placebo-controlled Trial of Oral Tetrahydrocannabinol (∆-9-THC) in Patients With Fibromyalgia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to evaluate the effectiveness of oral tetrahydrocannabinol in patients suffering from Fibromyalgia

Conditions

• Fibromyalgia

Interventions

Type	Name	Description
DRUG	Tetrahydrocannabinol	Oral solution of THC in concentration of 5mg/0.2ml. Dose regimen: 5mg 2-4 times/day as tolerated.
DRUG	Placebo	Orally administered olive oil. Dose: 0.2ml 2-4 times a day as tolerated

Timeline

• Start date: 2010-06-01
• Primary completion: 2012-07-01
• Completion: 2012-10-01
• First posted: 2010-06-23
• Last updated: 2010-06-23

Locations

1 site across 1 country: Israel